Evidence map›Paper›PMID 42444263›Full record

ArticleEuropean journal of neurology2026

Comorbidities and Complications in Parkinson's Disease in Primary Care.

Olaitan Okunoye, Laura Horsfall, Louise Marston, Kate Walters, Anette Schrag

Abstract read
In one paragraph

Article in European journal of neurology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Olaitan OkunoyeDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0003-0758-0987
Laura HorsfallInstitute of Health Informatics, University College London, London, UK.ORCID https://orcid.org/0000-0002-0868-5660
Louise MarstonDepartment of Primary Care and Population Health, University College London, London, UK.
Kate WaltersDepartment of Primary Care and Population Health, University College London, London, UK.ORCID https://orcid.org/0000-0003-2173-2430
Anette SchragDepartment of Clinical and Movement Neurosciences, University College London, London, UK.ORCID https://orcid.org/0000-0002-9872-6680

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundParkinson's disease (PD) is associated with an increased rate of mortality. It is unclear whether this is due to complications and comorbidities associated with the disease or the disease process of PD itself.

methodsWe undertook a cohort study in patients with PD in an electronic primary care record database. Mortality rate ratios and risk differences per 1000 person-years were calculated for each complication and comorbidity using multivariable Poisson regression analysis.

resultsThere were 10,104 patients with incident PD and 55,664 controls. The rate of falls, dementia, hallucinations, postural hypotension, stroke, depression, anxiety, sleep disorders, gastrointestinal and urinary disorders, headaches, epilepsy, and myocardial infarction was higher in individuals with PD compared to controls. Conversely, the rates of chronic obstructive pulmonary disease (COPD), congestive heart failure, and gout were lower. In the PD group, the comorbidities of dementia, falls, stroke, cancer, chronic heart failure, COPD, myocardial infarction, and gastrointestinal disorders were associated with higher mortality rates. However, for all comorbidities, the increase in mortality rate was similar to or lower in the PD group compared to people without PD, except for falls which tended to be associated with higher mortality in the PD group.

conclusionThis study provides data on the increased rate of mortality associated with different complications and comorbidities in PD. The mortality associated with these alone, however, does not explain the increased mortality in PD. This underscores the need for treatments to slow the underlying disease process.

Indexed as

Parkinson DiseasePrimary Health CareAgedAged, 80 and overCohort StudiesComorbidityFemaleHumansMaleMiddle AgedcomorbiditycomplicationsmortalityParkinson's diseaseprimary care

Identifiers

PMID42444263
PMCPMC13365866

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.